Immunohematology Global Market Report 2024

The immunohematology market has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.49 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historical period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and heightened awareness of transfusion-related risks.

The immunohematology market is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The anticipated growth in the forecast period can be attributed to the increasing demand for point-of-care testing, the emergence of novel blood products, the expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Key trends expected in the forecast period involve the adoption of automation and high-throughput systems, the implementation of molecular blood typing methods, advancements in antibody detection techniques, the promotion of patient blood management programs, the integration of AI in analysis, and the incorporation of telemedicine.

The anticipated rise in the prevalence of hematological disorders is set to drive the growth of the immunohematology market in the foreseeable future. Hematological disorders, affecting blood components such as red blood cells, white blood cells, platelets, and plasma, necessitate the use of immunohematology for safe and effective blood transfusions. This helps prevent transfusion reactions arising from incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques also play a crucial role in diagnosing and treating diseases impacting the immune system, with potential implications for the hematological system. For instance, Cancer Research UK reported an expected increase in new leukemia cases due to hematological disorders in the UK, rising from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the escalating prevalence of hematological disorders is a key driver behind the growth of the immunohematology market.

The aging population is anticipated to contribute significantly to the expansion of the immunohematology market. An aging population, characterized by a growing proportion of elderly individuals within a society or population, creates a demand for immunohematology to address age-related transfusion needs and ensure the safe use of blood products in medical interventions. The United States Census Bureau reported an increase in the country's median age to 38.9 years in 2022, indicating an ongoing trend of population aging. Therefore, the aging population is a significant factor driving the growth of the immunohematology market.

Technological advancements emerge as a prevalent trend in the immunohematology market, with major companies concentrating on innovative technologies to maintain their market standing. For instance, in October 2021, Ortho Clinical Diagnostics launched new capabilities for its Immediate Spin Crossmatch (ISXM) system, enhancing the comprehensive transfusion solution for ORTHO VISION and ORTHO VISION MAX Analyzers. This system streamlines and automates immunohematology testing and processing, particularly in identifying ABO blood type incompatibility during blood transfusions.

Major companies operating in the immunohematology market are innovating by introducing new products such as self-sampling blood collection products to enhance their market profitability. Self-sampling blood collection involves individuals collecting their own blood samples for diagnostic purposes without the need for healthcare professionals. For example, in February 2023, Capitainer launched CapitainerB 50, a self-sampling blood collection device that protects samples from contamination. The microsampling technology employed ensures precise quantitative sampling comparable to conventional pipetting.

In March 2023, Werfen, S.A., a diagnostic care company based in Spain, completed the acquisition of Immucor Inc. for approximately $2 billion. This strategic move aimed to expand Werfen's capabilities in specialized diagnostic testing, particularly within diagnostic solutions. Immucor Inc., a transfusion diagnostics company based in Spain, focuses on providing safe, accessible, and affordable blood tests.

Major companies operating in the immunohematology market report are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Harvard bioscience Inc., Cenogenics Corporation, Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Cellnovo Group, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2023. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main components of immunohematology include analyzers and systems, along with reagents. Analyzers and systems are automated instruments designed for blood typing and antibody screening. Various technologies are utilized in this field, such as biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR). These technologies are applied in the treatment of various diseases such as HIV and hepatitis. The diverse applications encompass pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology. The end-users of immunohematology products include blood banks, diagnostic and reference laboratories, hospitals, as well as academic and research institutes.

The immunohematology market research report provides immunohematology optical components market statistics, including immunohematology optical components industry global market size, regional shares, competitors with a immunohematology optical components market share, detailed immunohematology optical components market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology optical components industry. This immunohematology optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.